{"id":"https://openalex.org/W2806283749","doi":"https://doi.org/10.1097/01.hjh.0000538997.78835.f1","title":"TREATMENT WITH SGLT-2 INHIBITORS IN PATIENTS WITH DIABETES MELLITUS AND ESSENTIAL HYPERTENSION \u2013 DYNAMIC OF BLOOD PRESSURE VISIT-TO-VISIT VARIABILITY","display_name":"TREATMENT WITH SGLT-2 INHIBITORS IN PATIENTS WITH DIABETES MELLITUS AND ESSENTIAL HYPERTENSION \u2013 DYNAMIC OF BLOOD PRESSURE VISIT-TO-VISIT VARIABILITY","publication_year":2018,"publication_date":"2018-06-01","ids":{"openalex":"https://openalex.org/W2806283749","doi":"https://doi.org/10.1097/01.hjh.0000538997.78835.f1","mag":"2806283749"},"language":"en","primary_location":{"id":"doi:10.1097/01.hjh.0000538997.78835.f1","doi":"https://doi.org/10.1097/01.hjh.0000538997.78835.f1","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.hjh.0000538997.78835.f1","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057922213","display_name":"Larisa O. Minushkina","orcid":"https://orcid.org/0000-0002-4203-3586","observed_orcids":["https://orcid.org/0000-0002-4203-3586"]},"institutions":[{"id":"https://openalex.org/I4210106113","display_name":"Central State Medical Academy","ror":"https://ror.org/00xx5qr89","country_code":"RU","type":"education","lineage":["https://openalex.org/I2800573802","https://openalex.org/I4210106113"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"L. Minushkina","raw_affiliation_strings":["Central State Medical Academy of Department of Presidential Affairs, Moscow, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central State Medical Academy of Department of Presidential Affairs, Moscow, Russia","institution_ids":["https://openalex.org/I4210106113"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A.V. Kazakova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A.V. Kazakova","raw_affiliation_strings":["Policlinic 2 of Department of Presidential Affairs, Moscow, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Policlinic 2 of Department of Presidential Affairs, Moscow, Russia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110403521","display_name":"Matveeva Ls","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L.S. Matveeva","raw_affiliation_strings":["Policlinic 2 of Department of Presidential Affairs, Moscow, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Policlinic 2 of Department of Presidential Affairs, Moscow, Russia","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112367256","display_name":"S.V. Novosad","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S.V. Novosad","raw_affiliation_strings":["Policlinic 2 of Department of Presidential Affairs, Moscow, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Policlinic 2 of Department of Presidential Affairs, Moscow, Russia","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"Supplement 1","first_page":"e13","last_page":"e13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.9679999947547913},{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":1.0},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.8259999752044678},{"id":"https://openalex.org/keywords/essential-hypertension","display_name":"essential hypertension","score":0.996999979019165},{"id":"https://openalex.org/keywords/blood-pressure-variability","display_name":"blood pressure variability","score":0.9369999766349792},{"id":"https://openalex.org/keywords/visit-to-visit-variability","display_name":"visit-to-visit variability","score":0.9210000038146973},{"id":"https://openalex.org/keywords/ambulatory-blood-pressure-monitoring","display_name":"ambulatory blood pressure monitoring","score":0.8489999771118164},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8090000152587891},{"id":"https://openalex.org/keywords/antihypertensive-therapy","display_name":"antihypertensive therapy","score":0.9319999814033508},{"id":"https://openalex.org/keywords/antihypertensive-drug-discontinuation","display_name":"antihypertensive drug discontinuation","score":0.5230000019073486}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9582285284996033},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.785463809967041},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.7093226313591003},{"id":"https://openalex.org/C149323552","wikidata":"https://www.wikidata.org/wiki/Q3090739","display_name":"Ambulatory blood pressure","level":3,"score":0.6431237459182739},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6345915198326111},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6332541108131409},{"id":"https://openalex.org/C57900726","wikidata":"https://www.wikidata.org/wiki/Q492905","display_name":"Diastole","level":3,"score":0.6149203181266785},{"id":"https://openalex.org/C35785553","wikidata":"https://www.wikidata.org/wiki/Q756720","display_name":"Ambulatory","level":2,"score":0.5270258188247681},{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.45919856429100037},{"id":"https://openalex.org/C2777097880","wikidata":"https://www.wikidata.org/wiki/Q988405","display_name":"Essential hypertension","level":3,"score":0.44921520352363586},{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.43501999974250793},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.42100799083709717},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.33356553316116333},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.28499406576156616},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.2235051393508911}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/01.hjh.0000538997.78835.f1","doi":"https://doi.org/10.1097/01.hjh.0000538997.78835.f1","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.hjh.0000538997.78835.f1","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3166645977","https://openalex.org/W2391402283","https://openalex.org/W4315784608","https://openalex.org/W2478516668","https://openalex.org/W2375878489","https://openalex.org/W4282926457","https://openalex.org/W3107305517","https://openalex.org/W2374040709","https://openalex.org/W2951517483","https://openalex.org/W4282822747"],"abstract_inverted_index":{"Objective:":[0],"Aim":[1],"of":[2,9,152,160,181,192,245,264,327],"study":[3,35,207,265],"was":[4,55,168,177,208,226,252,329],"to":[5,33,258],"elucidate":[6],"possible":[7],"dynamic":[8],"blood":[10,275,344],"pressure":[11,174,276,345],"(BP)":[12],"level":[13],"and":[14,23,28,40,44,72,120,146,188,287,313,347,356],"BP":[15,133,164,193,201,215,224,233,299,328,349],"visit-to-visit":[16,190,350],"variability":[17,175,191,225,234,300,351],"in":[18,32,74,92,108,352],"patient":[19,256],"with":[20,38,70,76,98,143,247,334,340,354],"essential":[21],"hypertension(EH)":[22],"diabetes":[24],"mellitus":[25],"(DM).":[26],"Design":[27],"method:":[29],"We":[30,185],"included":[31],"the":[34,77,81,109,136,150,171,203,206,242,262],"26":[36],"patients":[37,95,101,112,122,155,161,266,353],"EH":[39,73,355],"DM":[41,71],"(13":[42],"male":[43],"13":[45,111,121],"women,":[46],"mean":[47,60],"age":[48],"62.5":[49],"\u00b1":[50,57,63,87,210,218,228,237,269,280,292,304,315],"7.98":[51],"years).":[52],"Mean":[53,199,222],"BMI":[54],"27.4":[56],"4.12":[58],"kg/m2,":[59],"GFR":[61],"69.4":[62],"11.87":[64],"ml/min/1,73":[65],"m2.":[66],"Patients":[67],"were":[68,96,113],"treated":[69,97,333],"accordance":[75],"current":[78],"recommendations.":[79],"At":[80,261],"enrollment":[82],"visit":[83],"they":[84],"receive":[85],"2,4":[86],"1,12":[88],"oral":[89,271],"hypoglycemic":[90,272,336],"agents":[91],"general,":[93],"6":[94,147,243],"insulin.":[99,260],"All":[100,154],"had":[102,130,162],"insufficient":[103],"glycemic":[104,250],"control":[105,251,346],"when":[106,332],"enrolled":[107],"study.":[110,172],"additionally":[114],"received":[115,156,267],"empagliflozin":[116],"10":[117,125],"mg":[118,126],"OD":[119],"\u2013":[123,216,235],"dapagliflozin":[124],"OD.":[127],"The":[128,325],"participants":[129],"their":[131],"office":[132],"measured":[134],"during":[135,170],"12-month":[137],"follow-up":[138],"(6":[139],"months":[140,148,244],"before":[141],"treatment":[142,167,246],"SGLT-2":[144,248,341],"inhibitors":[145,249,342],"after":[149],"beginning":[151],"treatment).":[153],"antihypertensive":[157],"therapy,":[158],"71%":[159],"good":[163],"control.":[165],"Antihypertension":[166],"stable":[169],"Blood":[173],"calculation":[176],"performed":[178],"per":[179],"data":[180],"electronic":[182],"ambulatory":[183],"cards.":[184],"defined":[186],"systolic":[187,200,223,309],"diastolic":[189,214,232,288,323],"using":[194],"average":[195],"real":[196],"variability.":[197],"Results:":[198],"at":[202],"inclusion":[204],"into":[205],"130.3":[209],"8.47":[211],"mm":[212,220,230,239,282,294,306,317],"Hg,":[213,231],"79.6":[217],"6.33":[219],"Hg.":[221,240],"9.41":[227],"1.83":[229],"6.64":[236],"0.51":[238],"After":[241],"better.":[253],"Only":[254],"1":[255],"continued":[257],"take":[259],"end":[263],"1,8":[268],"0,83":[270],"agents.":[273],"Systolic":[274],"decreased":[277,301],"by":[278,290,302],"5.2":[279],"10.18":[281],"Hg":[283,295,307,318],"(p":[284,296,310,319],"=":[285,297,320],"0.020)":[286],"-":[289],"2.7":[291],"6.11":[293],"0.037).":[298],"4.5":[303],"6.45":[305],"for":[308,322],"<":[311],"0.001)":[312],"0.8":[314],"1.79":[316],"0.056)":[321],"BP.":[324],"dynamics":[326],"not":[330],"different":[331,335],"drugs.":[337],"Conclusions:":[338],"Therapy":[339],"improves":[343],"decrease":[348],"DM.":[357]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2018-06-13T00:00:00"}